Protagenic (PTIX) Executive Chair Armen Garo H Buys 26,291 Shares

What Happened

• Armen Garo H, Executive Chair, Principal Officer and Director of Protagenic Therapeutics, purchased 26,291 shares reported as a Purchase (code P) on 2026-07-30. The reported price was $0.18 per share for a total consideration of $4,806. This was a purchase (often viewed as a more informative / potentially bullish insider action than a sale).

Key Details

• Transaction date: 2026-07-30; Report filed with SEC: 2026-08-03 (Form 4, Accession No. 0001493152-26-035868).
• Price and amount: 26,291 shares at $0.18 each; total reported value $4,806.
• Transaction type: P = purchase (open market or private purchase as reported).
• Shares owned after transaction: not specified in the excerpt provided.
• Footnotes/notable flags: none disclosed in the provided data.
• Filing timeliness: filed on 2026-08-03 — within the typical 2-business-day Form 4 deadline for a 2026-07-30 trade.

Context

• Purchases by insiders can be interpreted by investors as a signal of confidence, but they are just one data point; do not assume motives from the trade alone. No option exercises, gifts, or tax-withholding events were reported in the provided transaction details.